Azenta, Inc. (FRA:BA3)
| Market Cap | 1.50B |
| Revenue (ttm) | 506.11M |
| Net Income (ttm) | -47.53M |
| Shares Out | n/a |
| EPS (ttm) | -1.04 |
| PE Ratio | n/a |
| Forward PE | 47.97 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | n/a |
| Open | 28.40 |
| Previous Close | 28.20 |
| Day's Range | 28.40 - 28.40 |
| 52-Week Range | 21.80 - 52.50 |
| Beta | n/a |
| RSI | 66.07 |
| Earnings Date | Feb 5, 2026 |
About Azenta
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sampl... [Read more]
Financial Performance
In 2025, Azenta's revenue was $593.82 million, an increase of 3.55% compared to the previous year's $573.45 million. Losses were -$55.76 million, -66.18% less than in 2024.
Financial numbers in USD Financial StatementsNews
Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day
Vale stands out as Bull of the Day after a strong turnaround, rising production and a nearly 7% dividend push shares to new highs.
Bear of the Day: Azenta (AZTA)
2025 was another turbulent year for Azenta (AZTA) stock, which fell more than 30% as the medical solutions provider struggled with ongoing sales weakness.
New Strong Sell Stocks for December 30th
ASBFY, AZTA and ALG have been added to the Zacks Rank #5 (Strong Sell) List on December 30, 2025.
Azenta's Subsidiary To Sell B Medical Systems Business To THELEMA For $63 Mln
(RTTNews) - Azenta, Inc. (AZTA), Monday announced that its affiliate, Azenta Germany GmbH, has signed an agreement to sell its B Medical Systems business, a manufacturer and distributor of medical ref...
Azenta (AZTA) to Divest B Medical Systems for $63 Million
Azenta (AZTA) to Divest B Medical Systems for $63 Million
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.
BURLINGTON, Mass. , Dec. 29, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical...
Azenta (AZTA): Needham Analyst Raises Price Target to $44 | AZTA Stock News
Azenta (AZTA): Needham Analyst Raises Price Target to $44 | AZTA Stock News
New Strong Sell Stocks for Dec. 15
ALG, AZTA and CMG have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 15, 2025.
Azenta, Inc. (AZTA) Analyst/Investor Day Transcript
Azenta Inc To Host Investor Day Transcript
Azenta Inc To Host Investor Day Transcript
Azenta, Inc. (AZTA) Analyst/Investor Day - Slideshow
2025-12-10. The following slide deck was published by Azenta, Inc.
Azenta Authorizes $250 Million Share Repurchase Program
BURLINGTON, Mass. , Dec. 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved a share repurchase program under which the company may repurchase...
Azenta (AZTA) Schedules Investor Day for December
Azenta (AZTA) Schedules Investor Day for December
New Strong Sell Stocks for December 9th
BRBR, AZTA and BRDCY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2025.
Why a $5 Million Bet on Azenta Could Pay Off After a 70% Stock Slide
A major earnings reset and fresh fund interest could mark a turning point for this formerly high-flying life-sciences stock.
Azenta: Life Science Player Coming To Life
Decoding Azenta Inc (AZTA): A Strategic SWOT Insight
Decoding Azenta Inc (AZTA): A Strategic SWOT Insight
Raymond James Raises Price Target on Azenta (AZTA) to $45 | AZTA Stock News
Raymond James Raises Price Target on Azenta (AZTA) to $45 | AZTA Stock News
Azenta, Inc. 2025 Q4 - Results - Earnings Call Presentation
2025-11-22. The following slide deck was published by Azenta, Inc.
Azenta Inc (AZTA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Azenta Inc (AZTA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Positioning Amid Challenges
Q4 2025 Azenta Inc Earnings Call Transcript
Q4 2025 Azenta Inc Earnings Call Transcript
Azenta outlines 3%–5% organic revenue growth and 300 bps margin expansion for 2026 amid operational overhaul
Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript
AZTA Crosses Above Key Moving Average Level
In trading on Friday, shares of Azenta Inc (Symbol: AZTA) crossed above their 200 day moving average of $32.09, changing hands as high as $34.00 per share. Azenta Inc shares are currently trading up a...
Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones gaining around 150 points on Friday. Shares of Ross Stores Inc (NASDAQ: ROST) rose sharply during Friday's session after the company reported better-than-ex...